ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
08/19/2026
Back to search
Official data from USPTO
NEUROCRINE BIOSCIENCES
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
51
Latest update
08/19/2026
Trademark type
Combined
Nice classes
44
Filing date
08/16/2021
Registration date
11/04/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/04/2025
Last transaction
08/19/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
04/24/2024
First use in commerce
04/24/2024
Drawing code
3
Owner type
03
Owner location
San Diego, CA, US
Examiner
CHHINA, KARANENDRA S
Law office
M50
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of a stylized circular spiral design with the top spiral piece in aqua blue, the right one starting is aqua blue on the left and fading to pink on the right and the left one in pink with "NEUROCRINE" above "BIOSCIENCES" in block lettering to the right where NEUROCRINE is fading from a darker shade of aqua blue on the left to a lighter shade on the right and BIOSCIENCES in gray.
Holders and representatives
Holders
Neurocrine Biosciences, Inc.
Representatives
Allison Strickland Ricketts Fross Zelnick Lehrman & Zissu, P.C.
Technical classification
Nice Classes
Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 44
Providing medical information in the field of hormonal and genetic diseasesdisorders and conditions; on-line information servicesproviding medical information in the field of hormonal and genetic diseasesdisorders and conditions
Publications
History of USPTO decisions and trademark events.
51 publications found
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/04/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
11/04/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
10/13/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
10/13/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/05/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/05/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/05/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
08/01/2025
DPCC
DIVISIONAL PROCESSING COMPLETE
08/01/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
07/30/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/20/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03/20/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
03/20/2025
IUAF
USE AMENDMENT FILED
02/06/2025
DRRR
DIVISIONAL REQUEST RECEIVED
02/06/2025
EISU
TEAS STATEMENT OF USE RECEIVED
02/06/2025
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
02/06/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
08/05/2024
EX3G
SOU EXTENSION 3 GRANTED
08/05/2024
EXT3
SOU EXTENSION 3 FILED
08/05/2024
EEXT
SOU TEAS EXTENSION RECEIVED
08/05/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
10/25/2023
NOAC
CORRECTED NOA E-MAILED
10/25/2023
EX2G
SOU EXTENSION 2 GRANTED
10/24/2023
DPCC
DIVISIONAL PROCESSING COMPLETE
10/24/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
10/20/2023
EXT2
SOU EXTENSION 2 FILED
10/09/2023
DRRR
DIVISIONAL REQUEST RECEIVED
10/09/2023
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
10/09/2023
EEXT
SOU TEAS EXTENSION RECEIVED
10/09/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/18/2023
EX1G
SOU EXTENSION 1 GRANTED
07/14/2023
EXT1
SOU EXTENSION 1 FILED
07/14/2023
EEXT
SOU TEAS EXTENSION RECEIVED
07/14/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
02/07/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/13/2022
PUBO
PUBLISHED FOR OPPOSITION
12/13/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/23/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/05/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/05/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/04/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/04/2022
GEAN
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
05/05/2022
GEAP
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
05/05/2022
EPEN
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
05/05/2022
CPEA
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
05/05/2022
DOCK
ASSIGNED TO EXAMINER
05/03/2022
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
10/06/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/05/2021
NWAP
NEW APPLICATION ENTERED
08/19/2021
Continuous trademark protection
Get notified about every new filing that threatens NEUROCRINE BIOSCIENCES or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.